Reported Q: Q4 2025 Rev YoY: +5.9% EPS YoY: +11.5% Move: -0.13%
Revvity Inc
0KHE.L
$99.45 -0.13%
Exchange LSE Sector Healthcare Industry Medical Diagnostics Research
Q4 2025
Published: Feb 2, 2026

Company Status Snapshot

Fast view of the latest quarter outcome for 0KHE.L

Reported

Report Date

Feb 2, 2026

Quarter Q4 2025

Revenue

772.06M

YoY: +5.9%

EPS

0.87

YoY: +11.5%

Market Move

-0.13%

Previous quarter: Q3 2025

Follow this company to get upcoming quarter alerts automatically.

Earnings Highlights

  • Revenue of $772.06M up 5.9% year-over-year
  • EPS of $0.87 increased by 11.5% from previous year
  • Gross margin of 54.6%
  • Net income of 98.36M
  • "N/A" - N/A
0KHE.L
Company 0KHE.L

Executive Summary

Revvity Inc reported a solid Q4 2025 with topline growth and pronounced leverage to cash generation, even as operating profitability showed a mixed trajectory. Revenue reached $772.1 million for the quarter, up 5.9% year-over-year and 10.5% quarter-over-quarter, while gross profit rose to $421.7 million, delivering a gross margin of 54.6%. The company posted an operating income of $96.0 million and net income of $98.4 million, translating to an EPS of $0.87. A notable feature of the quarter was a tax benefit of $6.8 million, which contributed to a stronger net income print despite a year-ago operating margin decline. Free cash flow was exceptionally strong at $161.8 million, supported by operating cash flow of $182.0 million and modest capital expenditures of $20.2 million, underscoring Revvity’s capacity to fund growth initiatives, debt reduction (if any), and potential capital allocation opportunities.

Key Performance Indicators

Revenue
Increasing
772.06M
QoQ: 10.46% | YoY: 5.85%
Gross Profit
Increasing
421.66M
54.62% margin
QoQ: 12.56% | YoY: 17.23%
Operating Income
Decreasing
96.01M
QoQ: 17.23% | YoY: -27.43%
Net Income
Increasing
98.36M
QoQ: 110.85% | YoY: 3.50%
EPS
Increasing
0.87
QoQ: 117.50% | YoY: 11.54%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q4 2025 772.06 0.87 +5.9% View
Q3 2025 698.95 0.40 -4.2% View
Q2 2025 720.28 0.47 +5.3% View
Q1 2025 664.76 0.34 -2.8% View
Q4 2024 729.37 0.78 +5.5% View